Literature DB >> 17312057

Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.

John H Sampson1, Raghu Raghavan, James M Provenzale, David Croteau, David A Reardon, R Edward Coleman, Inmaculada Rodríguez Ponce, Ira Pastan, Raj K Puri, Christoph Pedain.   

Abstract

OBJECTIVE: Convection-enhanced delivery is a promising approach to intracerebral drug delivery in which a fluid pressure gradient is used to infuse therapeutic macromolecules through an indwelling catheter into the interstitial spaces of the brain. Our purpose was to test the hypothesis that hyperintense signal changes on T2-weighted images produced by such infusions can be used to track drug distribution. SUBJECTS AND METHODS: Seven adults with recurrent malignant glioma underwent concurrent intracerebral infusions of the tumor-targeted cytotoxin cintredekin besudotox and 123I-labeled human serum albumin. The agents were administered through a total of 18 catheters among the seven patients. Adequacy of distribution of drug was determined by evidence of distribution of 123I-labeled human serum albumin on SPECT images coregistered with MR images. Qualitative analysis was performed by three blinded observers. Quantitative analysis also was performed.
RESULTS: Infusions into 12 catheters produced intraparenchymal distribution as seen on SPECT images, but infusions into six catheters did not. At qualitative assessment of signal changes on MR images, reviewers correctly predicted which catheters would produce extraparenchymal distribution and which catheters would produce parenchymal distribution. Of the 12 infusions that produced intraparenchymal distribution, four catheters had been placed in regions of relatively normal signal intensity and produced regions of newly increased signal intensity, the volume of which highly correlated with the volume and geometry of distribution on SPECT (r2 = 0.9502). Eight infusions that produced intraparenchymal distribution were performed in regions of preexisting hyperintense signal. In these brains, additional signal changes were always produced, but quantitative correlations between areas of newly increased signal intensity and the volume and geometry of distribution on SPECT could not be established.
CONCLUSION: Convection-enhanced infusions frequently do not provide intraparenchymal drug distribution, and these failures can be identified with MRI soon after infusion. When infusions are performed into regions of normal signal intensity, development of hyperintense signal change strongly correlates with the volume and geometry of distribution of infusate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312057     DOI: 10.2214/AJR.06.0428

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

1.  Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain.

Authors:  R Mark Richardson; Adrian P Kells; Alastair J Martin; Paul S Larson; Philip A Starr; Peter G Piferi; Geoffrey Bates; Lisa Tansey; Kathryn H Rosenbluth; John R Bringas; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Stereotact Funct Neurosurg       Date:  2011-04-14       Impact factor: 1.875

2.  Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321.

Authors:  Dale Ding; Charles W Kanaly; Thomas J Cummings; James E Herndon; Raghu Raghavan; John H Sampson
Journal:  Neurol Res       Date:  2009-12-21       Impact factor: 2.448

Review 3.  Convection-Enhanced Delivery.

Authors:  A M Mehta; A M Sonabend; J N Bruce
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

4.  Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations.

Authors:  Mark M Souweidane; Justin F Fraser; Lisa M Arkin; Dolan Sondhi; Neil R Hackett; Stephen M Kaminsky; Linda Heier; Barry E Kosofsky; Stefan Worgall; Ronald G Crystal; Michael G Kaplitt
Journal:  J Neurosurg Pediatr       Date:  2010-08       Impact factor: 2.375

Review 5.  Imaging of Convective Drug Delivery in the Nervous System.

Authors:  Russell R Lonser
Journal:  Neurosurg Clin N Am       Date:  2017-08-19       Impact factor: 2.509

6.  Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.

Authors:  R Mark Richardson; Adrian P Kells; Kathryn H Rosenbluth; Ernesto Aguilar Salegio; Massimo S Fiandaca; Paul S Larson; Philip A Starr; Alastair J Martin; Russell R Lonser; Howard J Federoff; John R Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2011-02-22       Impact factor: 11.454

Review 7.  Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation.

Authors:  Marianela Candolfi; Kurt M Kroeger; Weidong Xiong; Chunyan Liu; Mariana Puntel; Kader Yagiz; Akm Ghulam Muhammad; Yohei Mineharu; David Foulad; Mia Wibowo; Hikmat Assi; Gregory J Baker; Pedro R Lowenstein; Maria G Castro
Journal:  Anticancer Agents Med Chem       Date:  2011-10       Impact factor: 2.505

8.  Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery.

Authors:  Rajiv R Iyer; John A Butman; Stuart Walbridge; Neville D Gai; John D Heiss; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-06-10       Impact factor: 5.115

9.  Evaluation of pressure-driven brain infusions in nonhuman primates by intra-operative 7 Tesla MRI.

Authors:  Kathryn H Rosenbluth; Alastair J Martin; John Bringas; Krystof S Bankiewicz
Journal:  J Magn Reson Imaging       Date:  2012-08-07       Impact factor: 4.813

Review 10.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.